Loading clinical trials...
Loading clinical trials...
Patients will be enrolled based on presence of HCC and eligibility for TACE. They will be randomized to one of two arms for imaging navigation to the optimal catheter location for chemotherapy injecti...
Bring this clarity to your next appointment.
Keep all your medical notes and next steps in one place.
Lead Sponsor
Stanford University
Collaborators
NCT06571396 · Carcinoma, Hepatocellular, Immunotherapy
NCT06454578 · Carcinoma, Hepatocellular
NCT05870969 · Carcinoma, Hepatocellular, Hepatitis C, Chronic, and more
NCT02221778 · Carcinoma, Hepatocellular
NCT05389527 · Carcinoma, Hepatocellular
Stanford University School of Medicine
Stanford, California
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions